pharma news today glp-1 obesity Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness India's fast-growing weight-loss drug market

It is conceivable that metformin may be able to potentiate or strengthen the vascular protective effects of GLP-1 and its analogues

Flint A, Raben A, Astrup A, and Holst JJ

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), a category of antidiabetic medications such as semaglutide and liraglutide, have dramatically improved outcomes in the treatment of T2D and obesity, significantly reducing complications from their metabolic consequences including cardiovascular and chronic kidney disease [20, 21]

How will it affect the obesity drug market

Begin Your New Chapter

GLP-1 medications are being studied for brain-health and neurodegenerative conditions, but research protocols are not the same thing as informal microdosing claims